You believe the value is diminishing as we approach the Top Line Phase II Data Read Out?
That would be an indictment of Managements ability to impart actual $$$ Value from a long awaited and SH funded Trial Process...
I'll be waiting to see the run Phase II Data supplies and whether there is a deal in the air but lack of Company promotion and current market awareness is hampering increased SH Value.... if you take into account circa $30m ++? to date on the Phase I and Phase II for SNT 5505 and lets call it 4+ years of development on the SH ticket ,, you would expect SNT Management to be extracting every cent of SH value from this Catalyst..
Next month will fully demonstrate Managements Commercial abilities ,, for me the Science is in the Bag,, now its what value Management can attribute to the Progress and the Trial Results...
Biotech has certainly been delivering with a solid recovery over the past week
Hope everyone has an awesome Friday NZT
SNT Price at posting:
6.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)